6OS2
Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to TRV026
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 23-ID-B |
| Synchrotron site | APS |
| Beamline | 23-ID-B |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2018-11-21 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 1.033 |
| Spacegroup name | I 2 2 2 |
| Unit cell lengths | 59.960, 101.350, 225.900 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 46.910 - 2.700 |
| R-factor | 0.2376 |
| Rwork | 0.233 |
| R-free | 0.28520 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6do1 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.17) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 46.910 | 46.910 | 2.770 |
| High resolution limit [Å] | 2.700 | 12.060 | 2.700 |
| Rmerge | 0.202 | 0.044 | 2.053 |
| Rmeas | 0.217 | 0.048 | 2.214 |
| Total number of observations | 144683 | ||
| Number of reflections | 19466 | 255 | 1390 |
| <I/σ(I)> | 6.87 | 27.95 | 0.66 |
| Completeness [%] | 99.7 | 97 | 97.7 |
| Redundancy | 7.433 | 6.42 | 6.913 |
| CC(1/2) | 0.996 | 0.999 | 0.453 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | LIPIDIC CUBIC PHASE | 8 | 293 | Protein complex was reconstituted with a 10:1 (w/w) mixture of monoolein and cholesterol. Crystals were grown in 100 mM Tris pH 8, 65 mM MgCl2, 26-28% PEG 300, 4.5% 1,3-butanediol |






